Label details recorded in the existing listing
- Wording in the artwork
- BELJARO EZUSE · TIRZEPATIDE 10 mg
- Brand identified by the listing/image
- Beligas
- Pictured format
- Beljaro EZUSE pen and carton
These details are transcribed from existing artwork, not product testing. Confirm contents against the actual label and documentation for that presentation.
What distinguishes this entry
Beljaro EZUSE is the pictured Beligas name, distinct from Lilly Mounjaro; product-specific interchangeability evidence is not supplied.
About Tirzepatide
Tirzepatide acts at GIP and GLP-1 receptors. Medicine evidence applies to the studied product and indication, not automatically to another brand.
Frequently asked questions
What name and presentation does the existing listing identify?
BELJARO EZUSE · TIRZEPATIDE 10 mg — Beljaro EZUSE pen and carton
What should this entry be distinguished from?
Beljaro EZUSE is the pictured Beligas name, distinct from Lilly Mounjaro; product-specific interchangeability evidence is not supplied.
What details help identify this listing in an enquiry?
Provide the name Tirzepatide Beljaro EZUSE Pen Beligas, this page link and a readable label image to identify the presentation. General enquiries: LINE @musclestationth.
Related information
Read about Tirzepatide · Browse Tirzepatide entries
Sources
Research and medicine labels above are separate from evidence for this listing image.
For general name or label questions, contact LINE: @musclestationth
